Cosmos Health Completes Phase 1 Execution of Liv18 Ahead of Schedule
Published on 04/20/2026 at 12:25 pm EDT
MT Newswires
Share

Share
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2508 USD | -7.42% |
|
+1.54% | -49.64% |
| Jun. 05 | Cosmos Health Inc. Announces U.S. Launch of Oliv18 Targeting Cardiovascular and Antioxidant Categories | CI |
| May. 26 | Cosmos Health targets $200 mln revenue, $44 mln adjusted EBITDA by 2029 | RE |
Published on 04/20/2026 at 12:25 pm EDT

Select your edition
All financial news and data tailored to specific country editions